<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font24">and </span>
   <span class="font16">for </span>
   <span class="font15">with </span>
   <span class="font14">COVID- </span>
   <span class="font14">SARS-CoV- </span>
   <span class="font13">drug </span>
   <span class="font13">are </span>
   <span class="font12">protein </span>
   <span class="font12">The </span>
   <span class="font12">clinical </span>
   <span class="font12">viral </span>
   <span class="font12">from </span>
   <span class="font12">that </span>
   <span class="font12">which </span>
   <span class="font12">against </span>
   <span class="font11">drugs </span>
   <span class="font11">ACE </span>
   <span class="font11">coronavirus </span>
   <span class="font11">human </span>
   <span class="font11">patients </span>
   <span class="font11">trial </span>
   <span class="font11">vaccine </span>
   <span class="font11">May </span>
   <span class="font11">Accessed </span>
   <span class="font11">receptor </span>
   <span class="font11">this </span>
   <span class="font11">protease </span>
   <span class="font11">was </span>
   <span class="font11">binding </span>
   <span class="font11">inhibitors </span>
   <span class="font11">cell </span>
   <span class="font11">host </span>
   <span class="font11">treatment </span>
   <span class="font11">virus </span>
   <span class="font11">cells </span>
   <span class="font11">{background </span>
   <span class="font11">also </span>
   <span class="font11">can </span>
   <span class="font11">has </span>
   <span class="font11">RNA </span>
   <span class="font11">approved </span>
   <span class="font11">potential </span>
   <span class="font11">respiratory </span>
   <span class="font10">entry </span>
   <span class="font10">stage), </span>
   <span class="font10">candidates </span>
   <span class="font10">developed </span>
   <span class="font10">docking </span>
   <span class="font10">followed </span>
   <span class="font10">may </span>
   <span class="font10">through </span>
   <span class="font10">treat </span>
   <span class="font10">COVID-. </span>
   <span class="font10">HCQ </span>
   <span class="font10">into </span>
   <span class="font10">spike </span>
   <span class="font10">trials </span>
   <span class="font10">two </span>
   <span class="font10">used </span>
   <span class="font10">[]. </span>
   <span class="font10">margin </span>
   <span class="font10">repurposing </span>
   <span class="font10">antiviral </span>
   <span class="font10">combination </span>
   <span class="font10">infection </span>
   <span class="font10">inhibitor </span>
   <span class="font10">{border-style </span>
   <span class="font10">new </span>
   <span class="font10">study </span>
   <span class="font10">these </span>
   <span class="font10">under </span>
   <span class="font10">Docking </span>
   <span class="font10">px;} </span>
   <span class="font10">silico </span>
   <span class="font10">targets </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">Fig. </span>
   <span class="font10">This </span>
   <span class="font10">along </span>
   <span class="font10">antibodies </span>
   <span class="font10">novel </span>
   <span class="font10">reported </span>
   <span class="font10">screening </span>
   <span class="font10">CLQ </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">have </span>
   <span class="font10">immune </span>
   <span class="font10">Used </span>
   <span class="font10">disease </span>
   <span class="font10">fusion </span>
   <span class="font10">inhibiting </span>
   <span class="font10">main </span>
   <span class="font10">monoclonal </span>
   <span class="font10">plasma </span>
   <span class="font10">proteins </span>
   <span class="font10">studies </span>
   <span class="font10">target </span>
   <span class="font10">were </span>
   <span class="font10">Phase-III </span>
   <span class="font10">Preprint </span>
   <span class="font10">based </span>
   <span class="font10">candidate </span>
   <span class="font10">compounds </span>
   <span class="font10">convalescent </span>
   <span class="font10">modeling </span>
   <span class="font10">possible </span>
   <span class="font10">preclinical </span>
   <span class="font10">severe </span>
   <span class="font10">(Fig. </span>
   <span class="font10">./chemrxiv..v </span>
   <span class="font10">China </span>
   <span class="font10">Institute </span>
   <span class="font10">its </span>
   <span class="font10">like </span>
   <span class="font10">most </span>
   <span class="font10">showed </span>
   <span class="font10">vaccines </span>
   <span class="font10">Medical </span>
   <span class="font10">action </span>
   <span class="font10">activity </span>
   <span class="font10">acute </span>
   <span class="font10">available </span>
   <span class="font10">caused </span>
   <span class="font10">complex </span>
   <span class="font10">data </span>
   <span class="font10">different </span>
   <span class="font10">mechanism </span>
   <span class="font10">natural </span>
   <span class="font10">not </span>
   <span class="font10">replication </span>
   <span class="font10">than </span>
   <span class="font10">their </span>
   <span class="font10">therapy </span>
   <span class="font10">using </span>
   <span class="font10">(NCT) </span>
   <span class="font10">FDA </span>
   <span class="font10">Mpro </span>
   <span class="font10">RF, </span>
   <span class="font10">Table </span>
   <span class="font10">Thus, </span>
   <span class="font10">analysis </span>
   <span class="font10">been </span>
   <span class="font10">domain </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">probable </span>
   <span class="font10">Due </span>
   <span class="font10">FDA-approved </span>
   <span class="font10">Research </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">ZINC </span>
   <span class="font10">angiotensin </span>
   <span class="font10">employing </span>
   <span class="font10">enzyme </span>
   <span class="font10">first </span>
   <span class="font10">identify </span>
   <span class="font10">lung </span>
   <span class="font10">membrane </span>
   <span class="font10">molecular </span>
   <span class="font10">molecules </span>
   <span class="font10">pneumonia </span>
   <span class="font10">recent </span>
   <span class="font10">responsible </span>
   <span class="font10">virtual </span>
   <span class="font10">(AutoDock </span>
   <span class="font10">ARDS </span>
   <span class="font10">ClinicalTrials.gov. </span>
   <span class="font10">Drug </span>
   <span class="font10">IL- </span>
   <span class="font10">Inhibits </span>
   <span class="font10">University </span>
   <span class="font10">Vaccine </span>
   <span class="font10">ZINC, </span>
   <span class="font10">acid </span>
   <span class="font10">animal </span>
   <span class="font10">antibody </span>
   <span class="font10">being </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">cytokine </span>
   <span class="font10">development </span>
   <span class="font10">https://clinicaltrials.gov/ct/show/NCT. </span>
   <span class="font10">identified </span>
   <span class="font10">infections </span>
   <span class="font10">research </span>
   <span class="font10">response </span>
   <span class="font10">small </span>
   <span class="font10">HIV- </span>
   <span class="font10">Med </span>
   <span class="font10">SARS </span>
   <span class="font10">already </span>
   <span class="font10">attachment </span>
   <span class="font10">block </span>
   <span class="font10">cases </span>
   <span class="font10">chloroquine </span>
   <span class="font10">computational </span>
   <span class="font10">days </span>
   <span class="font10">employed </span>
   <span class="font10">future </span>
   <span class="font10">inflammatory </span>
   <span class="font10">interaction </span>
   <span class="font10">other </span>
   <span class="font10">performed </span>
   <span class="font10">px; </span>
   <span class="font10">sequence </span>
   <span class="font10">sialic </span>
   <span class="font10">subunit </span>
   <span class="font10">there </span>
   <span class="font10">time </span>
   <span class="font10">use </span>
   <span class="font10">via </span>
   <span class="font10">{font-family </span>
   <span class="font10">(Zinc </span>
   <span class="font10">(monoclonal </span>
   <span class="font10">CLpro </span>
   <span class="font10">ID: </span>
   <span class="font10">Infect </span>
   <span class="font10">Mild: </span>
   <span class="font10">RdRp </span>
   <span class="font10">Serious: </span>
   <span class="font10">[], </span>
   <span class="font10">acts </span>
   <span class="font10">al. </span>
   <span class="font10">all </span>
   <span class="font10">antibody) </span>
   <span class="font10">any </span>
   <span class="font10">associated </span>
   <span class="font10">between </span>
   <span class="font10">database </span>
   <span class="font10">design </span>
   <span class="font10">discovery </span>
   <span class="font10">effective </span>
   <span class="font10">font-size </span>
   <span class="font10">form </span>
   <span class="font10">homology </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">including </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibit </span>
   <span class="font10">mouth </span>
   <span class="font10">one </span>
   <span class="font10">promising </span>
   <span class="font10">structural </span>
   <span class="font10">such </span>
   <span class="font10">surface </span>
   <span class="font10">system </span>
   <span class="font10">targeting </span>
   <span class="font10">thus </span>
   <span class="font10">type </span>
   <span class="font10">vitro </span>
   <span class="font10">will </span>
   <span class="font10">CYPA </span>
   <span class="font10">China, </span>
   <span class="font10">Chinese </span>
   <span class="font10">For </span>
   <span class="font10">GM-CSF </span>
   <span class="font10">LU, </span>
   <span class="font10">National </span>
   <span class="font10">Phase-I/II), </span>
   <span class="font10">RE, </span>
   <span class="font10">Res </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">acids </span>
   <span class="font10">act </span>
   <span class="font10">authors </span>
   <span class="font10">case </span>
   <span class="font10">cases, </span>
   <span class="font10">cells. </span>
   <span class="font10">cellular </span>
   <span class="font10">clinically </span>
   <span class="font10">control </span>
   <span class="font10">double; </span>
   <span class="font10">drug) </span>
   <span class="font10">essential </span>
   <span class="font10">every </span>
   <span class="font10">gangliosides </span>
   <span class="font10">going </span>
   <span class="font10">group </span>
   <span class="font10">mechanisms </span>
   <span class="font10">molecule </span>
   <span class="font10">multiple </span>
   <span class="font10">present </span>
   <span class="font10">produce </span>
   <span class="font10">recently </span>
   <span class="font10">related </span>
   <span class="font10">release </span>
   <span class="font10">role </span>
   <span class="font10">safety </span>
   <span class="font10">search </span>
   <span class="font10">status </span>
   <span class="font10">structure </span>
   <span class="font10">syndrome </span>
   <span class="font10">then </span>
   <span class="font10">therapeutic </span>
   <span class="font10">they </span>
   <span class="font10">three </span>
   <span class="font10">(developed </span>
   <span class="font10">-nCoV </span>
   <span class="font10">Although </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Center </span>
   <span class="font10">ClinicalTrials.gov </span>
   <span class="font10">Combination </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">DNA </span>
   <span class="font10">DrugBank </span>
   <span class="font10">Health </span>
   <span class="font10">Inhibit </span>
   <span class="font10">Molecular </span>
   <span class="font10">N-terminal </span>
   <span class="font10">PDB </span>
   <span class="font10">Phase-II </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Repurposing </span>
   <span class="font10">Ritonavir </span>
   <span class="font10">Science </span>
   <span class="font10">Smith </span>
   <span class="font10">Therapeutics </span>
   <span class="font10">Under </span>
   <span class="font10">University, </span>
   <span class="font10">Viral </span>
   <span class="font10">able </span>
   <span class="font10">active </span>
   <span class="font10">adults </span>
   <span class="font10">alpha </span>
   <span class="font10">among </span>
   <span class="font10">bind </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">combat </span>
   <span class="font10">containing </span>
   <span class="font10">crystal </span>
   <span class="font10">deep </span>
   <span class="font10">discussed </span>
   <span class="font10">disorders </span>
   <span class="font10">found </span>
   <span class="font10">health </span>
   <span class="font10">higher </span>
   <span class="font10">important </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">institutes </span>
   <span class="font10">investigation </span>
   <span class="font10">key </span>
   <span class="font10">lower </span>
   <span class="font10">mild </span>
   <span class="font10">more </span>
   <span class="font10">neutralizing </span>
   <span class="font10">nucleoside </span>
   <span class="font10">pandemic </span>
   <span class="font10">peptide </span>
   <span class="font10">polyproteins </span>
   <span class="font10">preventing </span>
   <span class="font10">production </span>
   <span class="font10">progress </span>
   <span class="font10">provides </span>
   <span class="font10">receptor-binding </span>
   <span class="font10">recommended </span>
   <span class="font10">recovered </span>
   <span class="font10">remdesivir </span>
   <span class="font10">review </span>
   <span class="font10">same </span>
   <span class="font10">several </span>
   <span class="font10">site </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">specific </span>
   <span class="font10">strategies </span>
   <span class="font10">theory </span>
   <span class="font10">therapeutics </span>
   <span class="font10">times </span>
   <span class="font10">tools </span>
   <span class="font10">transmission </span>
   <span class="font10">up-to-date </span>
   <span class="font10">various </span>
   <span class="font10">virus, </span>
   <span class="font10">website: </span>
   <span class="font10">world </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">(ATR) </span>
   <span class="font10">(Compounds </span>
   <span class="font10">(Mpro) </span>
   <span class="font10">(a) </span>
   <span class="font10">(antiviral) </span>
   <span class="font10">(as </span>
   <span class="font10">(b) </span>
   <span class="font10">ADMET </span>
   <span class="font10">After </span>
   <span class="font10">Approved </span>
   <span class="font10">Box </span>
   <span class="font10">CLQ, </span>
   <span class="font10">CYPA, </span>
   <span class="font10">Chemical </span>
   <span class="font10">Clinical </span>
   <span class="font10">Computational </span>
   <span class="font10">Dis </span>
   <span class="font10">February </span>
   <span class="font10">Gastrointestinal </span>
   <span class="font10">HIV </span>
   <span class="font10">Institute, </span>
   <span class="font10">Lys </span>
   <span class="font10">Medicine </span>
   <span class="font10">NSP </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">Phase-I </span>
   <span class="font10">Phase-I), </span>
   <span class="font10">Pneumonia </span>
   <span class="font10">QSAR </span>
   <span class="font10">Respiratory </span>
   <span class="font10">Schematic </span>
   <span class="font10">Sciences </span>
   <span class="font10">Trial </span>
   <span class="font10">acid, </span>
   <span class="font10">affinity </span>
   <span class="font10">al.A </span>
   <span class="font10">antagonist </span>
   <span class="font10">approaches </span>
   <span class="font10">better </span>
   <span class="font10">blocking </span>
   <span class="font10">bold </span>
   <span class="font10">both </span>
   <span class="font10">but </span>
   <span class="font10">cell, </span>
   <span class="font10">chain </span>
   <span class="font10">commercially </span>
   <span class="font10">companies </span>
   <span class="font10">courier; </span>
   <span class="font10">critically </span>
   <span class="font10">currently </span>
   <span class="font10">cytokines </span>
   <span class="font10">database, </span>
   <span class="font10">databases </span>
   <span class="font10">death </span>
   <span class="font10">depicted </span>
   <span class="font10">discussion </span>
   <span class="font10">docking, </span>
   <span class="font10">domains </span>
   <span class="font10">drugs, </span>
   <span class="font10">due </span>
   <span class="font10">effectiveness </span>
   <span class="font10">efficacy </span>
   <span class="font10">either </span>
   <span class="font10">em; </span>
   <span class="font10">existing </span>
   <span class="font10">expression </span>
   <span class="font10">factors </span>
   <span class="font10">fight </span>
   <span class="font10">financial </span>
   <span class="font10">further </span>
   <span class="font10">genomic </span>
   <span class="font10">global </span>
   <span class="font10">help </span>
   <span class="font10">here </span>
   <span class="font10">ill </span>
   <span class="font10">industries </span>
   <span class="font10">infected </span>
   <span class="font10">information </span>
   <span class="font10">inhibition </span>
   <span class="font10">injury </span>
   <span class="font10">interactions </span>
   <span class="font10">interface </span>
   <span class="font10">interferon </span>
   <span class="font10">knowledge </span>
   <span class="font10">leading </span>
   <span class="font10">lopinavir </span>
   <span class="font10">lopinavirâ€“ritonavir </span>
   <span class="font10">lungs </span>
   <span class="font10">mRNA </span>
   <span class="font10">made </span>
   <span class="font10">management </span>
   <span class="font10">many </span>
   <span class="font10">mesylate </span>
   <span class="font10">mice </span>
   <span class="font10">might </span>
   <span class="font10">model </span>
   <span class="font10">modeling. </span>
   <span class="font10">network </span>
   <span class="font10">non-structural </span>
   <span class="font10">number </span>
   <span class="font10">ongoing </span>
   <span class="font10">only </span>
   <span class="font10">outbreak </span>
   <span class="font10">partial </span>
   <span class="font10">patients. </span>
   <span class="font10">polymerase </span>
   <span class="font10">positive </span>
   <span class="font10">prevention </span>
   <span class="font10">processes </span>
   <span class="font10">produced </span>
   <span class="font10">properties </span>
   <span class="font10">pt;} </span>
   <span class="font10">pulmonary </span>
   <span class="font10">ritonavir </span>
   <span class="font10">serine </span>
   <span class="font10">similar </span>
   <span class="font10">stabilized </span>
   <span class="font10">stem </span>
   <span class="font10">strains </span>
   <span class="font10">synthesis </span>
   <span class="font10">tabulated </span>
   <span class="font10">testing </span>
   <span class="font10">them </span>
   <span class="font10">tract </span>
   <span class="font10">translated </span>
   <span class="font10">treated </span>
   <span class="font10">trials, </span>
   <span class="font10">trials. </span>
   <span class="font10">tried </span>
   <span class="font10">trying </span>
   <span class="font10">underway </span>
   <span class="font10">uses </span>
   <span class="font10">when </span>
   <span class="font10">who </span>
  </p>
 </body>
</html>
